Post-COVID-19 encephalomyelitis

Ji-Won Kim; Nuran Abdullayev; Janina Neuneier; Gereon R Fink; Helmar C Lehmann

doi:10.1186/s42466-021-00113-4

Post-COVID-19 encephalomyelitis

Neurol Res Pract. 2021 Mar 15;3(1):18. doi: 10.1186/s42466-021-00113-4.

Authors

Ji-Won Kim¹, Nuran Abdullayev², Janina Neuneier¹, Gereon R Fink^{1

3}, Helmar C Lehmann⁴

Affiliations

¹ Department of Neurology, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.
² Department of Radiology, University Hospital Cologne, Cologne, Germany.
³ Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, Jülich, Germany.
⁴ Department of Neurology, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany. [email protected].

Abstract

Since the outbreak of coronavirus disease 2019 (COVID-19), a growing number of cases of acute transverse myelitis associated with COVID-19 have been reported. Here, we present the case of a patient who developed sensory ataxia after COVID-19 with MR lesions suggestive for longitudinal myelitis and in the splenium of the corpus callosum. The patient was successfully treated with immunoadsorption.

Keywords: Autoimmunity; Myelitis; Neuromyelitis optica; Postinfectious.

Publication types

Letter